← 產業報告目錄

Asia Pacific Lancet and Pen Needles Market Research Report Information by Type (lancets and pen needles), Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide (GLP), Skin Testing, and Others), End Use (Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, Research & Academic Laboratories, and Others), by Region (China, India Japan, South Korea, Australia, and Rest of the Asia-Pacific) Forecast to 2032

出版商 Market Research Future產業別 Medical Devices出版日期 2024-08-20頁數 1112報告編號 MRF-df8087fcd5

授權報價

Single User Price$2,950 USD
Multi User Licence (up to 10 users)$3,950 USD
Enterprisewide Price (Global Site License)$5,250 USD
洽詢購買 申請 Sample

報告摘要

Asia Pacific Lancet and Pen Needles Market Research Report Information by Type (lancets and pen needles), Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide (GLP), Skin Testing, and Others), End Use (Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, Research & Academic Laboratories, and Others), by Region (China, India Japan, South Korea, Australia, and Rest of the Asia-Pacific) Forecast to 2032 Market Overview Asia Pacific Lancet and Pen Needles Market is anticipated to register a healthy market expansion a CAGR of 11.13% during the review period. Lancets are single-use gadgets/devices for narrow blood testing used by professionals in healthcare services. Lancets are a necessary part of the sharp-injury aversion programs in hospitals, clinics, research centers, and physicians’ offices. Lancets are one of the widely used alternative devices to obtain blood samples. Lancets and pen needles are receiving global recognition and acceptance due to their several convenient characteristics which gives them an edge over the traditional methods for vein puncture. A pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. The increasing incidences of diabetes across the Asia-Pacific region and strategic initiatives associated with pen needles by market players are the major factors driving the growth of the Asia-Pacific lancet and pen needles market. However, alternative technologies for drug delivery are expected to restrain the growth of the Asia-Pacific market. Nevertheless, the growing geriatric population in the Asia-Pacific region is anticipated to create lucrative opportunities for the market. Market Segmentation The Asia-Pacific lancet and pen needles market, based on type, has been segmented into lancets and pen needles. The lancet and pen needles market, based on application, has been segmented into insulin, capillary blood sampling, hormones, glucose like peptide (GLP), skin testing, and others. The lancet and pen needles market, based on end user, is divided into hospitals & clinics, diagnostic centers & medical institutions, home care & home diagnostics, research & academic laboratories, and others. Based on country, the Asia-Pacific lancet and pen needle market has been segmented into, China, India Japan, South Korea, Australia, and Rest of the Asia-Pacific. China accounted for the largest market share in 2022. However, India is projected to grow at the highest CAGR during the forecast period. Major Players The key market players are Novo Nordisk A/S, Terumo Corporation, B. Braun SE, Nipro Corporation, Abbott, and Cardinal Health.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 15 2 MARKET INTRODUCTION 17 2.1 DEFINITION 17 2.2 SCOPE OF THE STUDY 17 2.3 RESEARCH OBJECTIVE 17 2.4 MARKET STRUCTURE 18 3 RESEARCH METHODOLOGY 19 3.1 OVERVIEW 19 3.2 DATA FLOW 21 3.2.1 DATA MINING PROCESS 21 3.3 PURCHASED DATABASE: 22 3.4 SECONDARY SOURCES: 23 3.4.1 SECONDARY RESEARCH DATA FLOW: 24 3.5 PRIMARY RESEARCH: 25 3.5.1 PRIMARY RESEARCH DATA FLOW: 26 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 27 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 28 3.6.1 REVENUE ANALYSIS APPROACH 28 3.7 DATA FORECASTING 29 3.7.1 DATA FORECASTING TECHNIQUE 29 3.8 DATA MODELING 30 3.8.1 MICROECONOMIC FACTOR ANALYSIS: 30 3.8.2 DATA MODELING: 31 3.9 TEAMS AND ANALYST CONTRIBUTION 33 4 MARKET DYNAMICS 35 4.1 INTRODUCTION 35 4.2 DRIVERS 36 4.2.1 INCREASING INCIDENCES OF DIABETES ACROSS THE ASIA-PACIFIC REGION 36 4.2.2 STRATEGIC INITIATIVES ASSOCIATED WITH PEN NEEDLE IN BY MARKET PLAYERS 36 4.3 RESTRAINTS 38 4.3.1 ALTERNATIVE METHODS FOR DRUG DELIVERY 38   4.4 OPPORTUNITY 39 4.4.1 GROWING GERIATRIC POPULATION IN ASIA-PACIFIC REGION 39 5 MARKET FACTOR ANALYSIS 40 5.1 PORTER'S FIVE FORCES MODEL 40 5.1.1 THREAT OF NEW ENTRANTS 40 5.1.2 BARGAINING POWER OF SUPPLIERS 41 5.1.3 THREAT OF SUBSTITUTES 41 5.1.4 BARGAINING POWER OF BUYERS 41 5.1.5 INTENSITY OF RIVALRY 41 5.2 IMPACT OF COVID-19 ON THE ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET 42 6 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE 44 6.1 OVERVIEW 44 6.2 LANCET 45 6.2.1 SAFETY LANCET 47 6.2.1.1 PUSH BUTTON SAFETY LANCET 48 6.2.1.2 PRESSURE ACTIVATED SAFETY LANCET 48 6.2.1.3 SIDE BUTTON SAFETY LANCET 49 6.2.2 REGULAR LANCET 49 6.3 PEN NEEDLES 50 6.3.1 STANDARD NEEDLES 51 6.3.2 SAFETY NEEDLES 52 7 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY APPLICATION 53 7.1 OVERVIEW 53 7.2 INSULIN DELIVERY 55 7.3 CAPILLARY BLOOD SAMPLING 56 7.4 HORMONE DELIVERY 56 7.5 GLUCOSE LIKE PEPTIDE (GLP) DELIVERY 57 7.6 SKIN TESTING 57 7.7 OTHERS 58 8 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY END USER 59 8.1 OVERVIEW 59 8.2 HOSPITALS & CLINICS 61 8.3 DIAGNOSTIC CENTERS 62 8.4 HOME CARE & HOME DIAGNOSTICS 62 8.5 RESEARCH & ACADEMIC LABORATORIES 63 9 ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY COUNTRY 64 9.1 OVERVIEW 64 9.2 ASIA-PACIFIC 64 9.2.1 CHINA 66 9.2.2 INDIA 68 9.2.3 JAPAN 70 9.2.4 AUSTRALIA 72 9.2.5 SOUTH KOREA 74 9.2.6 REST OF ASIA-PACIFIC 76 10 COMPETITIVE LANDSCAPE 80 10.1 INTRODUCTION 80 10.2 MARKET SHARE ANALYSIS, 2022 80 10.3 COMPETITOR DASHBOARD 81 10.4 PUBLIC PLAYERS STOCK SUMMARY 82 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 82 11 COMPANY PROFILES 83 11.1 NOVO NORDISK A/S 83 11.1.1 COMPANY OVERVIEW 83 11.1.2 FINANCIAL OVERVIEW 84 11.1.3 PRODUCTS OFFERED 84 11.1.4 KEY DEVELOPMENTS 85 11.1.5 SWOT ANALYSIS 85 11.1.6 KEY STRATEGIES 86 11.2 TERUMO CORPORATION 87 11.2.1 COMPANY OVERVIEW 87 11.2.2 FINANCIAL OVERVIEW 88 11.2.3 PRODUCTS OFFERED 88 11.2.4 KEY DEVELOPMENTS 89 11.2.5 SWOT ANALYSIS 89 11.2.6 KEY STRATEGIES 89 11.3 PHOENIX HEALTHCARE SOLUTIONS, LLC 90 11.3.1 COMPANY OVERVIEW 90 11.3.2 FINANCIAL OVERVIEW 90 11.3.3 PRODUCTS OFFERED 90 11.3.4 KEY DEVELOPMENTS 90 11.3.5 KEY STRATEGIES 91 11.4 CARDINAL HEALTH 92 11.4.1 COMPANY OVERVIEW 92 11.4.2 FINANCIAL OVERVIEW 93 11.4.3 PRODUCTS OFFERED 93 11.4.4 KEY DEVELOPMENTS 94 11.4.5 SWOT ANALYSIS 94 11.4.6 KEY STRATEGIES 94 11.5 NANCHANG YILI MEDICAL INSTRUMENT CO., LTD 95 11.5.1 COMPANY OVERVIEW 95 11.5.2 FINANCIAL OVERVIEW 95 11.5.3 PRODUCTS OFFERED 95 11.5.4 KEY DEVELOPMENTS 96 11.5.5 KEY STRATEGY 96 11.6 ABBOTT 97 11.6.1 COMPANY OVERVIEW 97 11.6.2 FINANCIAL OVERVIEW 98 11.6.3 PRODUCTS OFFERED 98 11.6.4 KEY DEVELOPMENTS 99 11.6.5 SWOT ANALYSIS 99 11.6.6 KEY STRATEGIES 99 11.7 JIANGSU HUIDA MEDICAL INSTRUMENTS CO., LTD 100 11.7.1 COMPANY OVERVIEW 100 11.7.2 FINANCIAL OVERVIEW 100 11.7.3 PRODUCTS OFFERED 100 11.7.4 KEY DEVELOPMENTS 100 11.7.5 KEY STRATEGIES 101 11.8 B. BRAUN SE 102 11.8.1 COMPANY OVERVIEW 102 11.8.2 FINANCIAL OVERVIEW 103 11.8.3 PRODUCTS OFFERED 104 11.8.4 KEY DEVELOPMENTS 104 11.8.5 SWOT ANALYSIS 104 11.8.6 KEY STRATEGIES 105   11.9 NIPRO CORPORATION 106 11.9.1 COMPANY OVERVIEW 106 11.9.2 FINANCIAL OVERVIEW 107 11.9.3 PRODUCTS OFFERED 107 11.9.4 KEY DEVELOPMENTS 107 11.9.5 KEY STRATEGIES 108 11.10 ADVACARE PHARMA 109 11.10.1 COMPANY OVERVIEW 109 11.10.2 FINANCIAL OVERVIEW 109 11.10.3 PRODUCTS OFFERED 109 11.10.4 KEY DEVELOPMENTS 109 11.10.5 KEY STRATEGIES 110 12 DATA CITATIONS 111
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 31 TABLE 2 NUMBER OF INDIVIDUALS WITH DIABETES, BY COUNTRY (2022) 36 TABLE 3 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2019–2032 (USD MILLION) 44 TABLE 4 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR LANCET, BY COUNTRY, 2019–2032 (USD MILLION) 46 TABLE 5 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 46 TABLE 6 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SAFETY LANCET, BY COUNTRY, 2019–2032 (USD MILLION) 47 TABLE 7 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 47 TABLE 8 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PUSH BUTTON SAFETY LANCET, BY COUNTRY, 2019–2032 (USD MILLION) 48 TABLE 9 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PRESSURE ACTIVATED SAFETY LANCET, BY COUNTRY, 2019–2032 (USD MILLION) 48 TABLE 10 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SIDE BUTTON SAFETY LANCET, BY COUNTRY, 2019–2032 (USD MILLION) 49 TABLE 11 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR REGULAR LANCET, BY COUNTRY, 2019–2032 (USD MILLION) 49 TABLE 12 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PEN NEEDLES, BY COUNTRY, 2019–2032 (USD MILLION) 51 TABLE 13 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 51 TABLE 14 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR STANDARD NEEDLES, BY COUNTRY, 2019–2032 (USD MILLION) 51 TABLE 15 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SAFETY NEEDLES, BY COUNTRY, 2019–2032 (USD MILLION) 52 TABLE 16 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 54 TABLE 17 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR INSULIN DELIVERY, BY COUNTRY, 2019–2032 (USD MILLION) 55 TABLE 18 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR CAPILLARY BLOOD SAMPLING, BY COUNTRY, 2019–2032 (USD MILLION) 56 TABLE 19 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR HORMONE DELIVERY, BY COUNTRY, 2019–2032 (USD MILLION) 56 TABLE 20 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR GLUCOSE LIKE PEPTIDE (GLP) DELIVERY, BY COUNTRY, 2019–2032 (USD MILLION) 57 TABLE 21 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SKIN TESTING, BY COUNTRY, 2019–2032 (USD MILLION) 57 TABLE 22 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 58 TABLE 23 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY END USER, 2019–2032 (USD MILLION) 60 TABLE 24 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2032 (USD MILLION) 61 TABLE 25 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2019–2032 (USD MILLION) 62 TABLE 26 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR HOME CARE & HOME DIAGNOSTICS, BY COUNTRY, 2019–2032 (USD MILLION) 62 TABLE 27 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR RESEARCH & ACADEMIC LABORATORIES BY COUNTRY, 2019–2032 (USD MILLION) 63 TABLE 28 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 65 TABLE 29 CHINA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019–2032 (USD MILLION) 66 TABLE 30 CHINA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 66 TABLE 31 CHINA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 67 TABLE 32 CHINA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 67 TABLE 33 CHINA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 67 TABLE 34 CHINA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 68 TABLE 35 INDIA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019–2032 (USD MILLION) 68 TABLE 36 INDIA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 68 TABLE 37 INDIA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 69 TABLE 38 INDIA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 69 TABLE 39 INDIA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 69 TABLE 40 INDIA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 70 TABLE 41 JAPAN LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019–2032 (USD MILLION) 70 TABLE 42 JAPAN LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 70 TABLE 43 JAPAN LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 71 TABLE 44 JAPAN LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 71 TABLE 45 JAPAN LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 71 TABLE 46 JAPAN LANCET AND PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 72 TABLE 47 AUSTRALIA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019–2032 (USD MILLION) 72 TABLE 48 AUSTRALIA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 72 TABLE 49 AUSTRALIA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 73 TABLE 50 AUSTRALIA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 73 TABLE 51 AUSTRALIA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 73 TABLE 52 AUSTRALIA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 74 TABLE 53 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019–2032 (USD MILLION) 74 TABLE 54 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 74 TABLE 55 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 75 TABLE 56 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 75 TABLE 57 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 75 TABLE 58 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 76 TABLE 59 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019–2032 (USD MILLION) 76 TABLE 60 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019–2032 (USD MILLION) 76 TABLE 61 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019–2032 (USD MILLION) 77 TABLE 62 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019–2032 (USD MILLION) 77 TABLE 63 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 77 TABLE 64 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 78 TABLE 65 PUBLIC PLAYERS STOCK SUMMARY 82 TABLE 66 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 82 TABLE 67 NOVO NORDISK A/S: PRODUCTS OFFERED 84 TABLE 68 TERUMO CORPORATION: PRODUCTS OFFERED 88 TABLE 69 PHOENIX HEALTHCARE SOLUTIONS, LLC: PRODCUTS OFFERED 90 TABLE 70 CARDINAL HEALTH: PRODUCTS OFFERED 93 TABLE 71 NANCHANG YILI MEDICAL INSTRUMENT CO., LTD: PRODUCTS OFFERED 95 TABLE 72 ABBOTT: PRODUCTS OFFERED 98 TABLE 73 JIANGSU HUIDA MEDICAL INSTRUMENTS CO., LTD: PRODUCTS OFFERED 100 TABLE 74 B. BRAUN SE: PRODUCTS OFFERED 104 TABLE 75 NIPRO CORPORATION: PRODUCTS OFFERED 107 TABLE 76 ADVACARE PHARMA: PRODCUTS OFFERED 109 LIST OF FIGURES FIGURE 1 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET: STRUCTURE 18 FIGURE 2 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 35 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 37 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 38 FIGURE 5 NUMBER OF PEOPLE AGED 60 YEARS OR OVER IN ASIA-PACIFIC, BY SUBREGION, 2022, 2030 AND 2050 39 FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET 40 FIGURE 7 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022 & 2032 (USD MILLION) 44 FIGURE 8 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET SHARE (%), BY TYPE, 2022 45 FIGURE 9 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 54 FIGURE 10 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET SHARE (%), BY APPLICATION, 2022 55 FIGURE 11 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY END USER, 2022 & 2032 (USD MILLION) 60 FIGURE 12 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET SHARE (%), BY END USER, 2022 61 FIGURE 13 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET, 2019-2032 (USD MILLION) 64 FIGURE 14 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 65 FIGURE 15 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET SHARE (%), BY COUNTRY, 2022 66 FIGURE 16 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 80 FIGURE 17 COMPETITOR DASHBOARD: ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET 81 FIGURE 18 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT 84 FIGURE 19 NOVO NORDISK A/S: SWOT ANALYSIS 85 FIGURE 20 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 88 FIGURE 21 TERUMO CORPORATION: SWOT ANALYSIS 89 FIGURE 22 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT 93 FIGURE 23 CARDINAL HEALTH: SWOT ANALYSIS 94 FIGURE 24 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 98 FIGURE 25 ABBOTT: SWOT ANALYSIS 99 FIGURE 26 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 103 FIGURE 27 B. BRAUN SE: SWOT ANALYSIS 104 FIGURE 28 NIPRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 107

提及公司

Novo Nordisk A/STerumo CorporationB. Braun SENipro CorporationAbbottand Cardinal Health

同分類最新報告(醫療器材)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們